RB1 and neoplasm: Loss of the RB1 tumor suppressor plays a key role in unveiling epigenetic heterogeneity in advanced cancers.162–166 While the direct transcriptional activity derived from RB1 inactivation may not be pharmacologically targetable yet, RB1 inactivation leads to increase of dependency on enzymatic targets susceptible for pharmacological inhibition.